openPR Logo
Press release

Metagenomics Market 2024 - Providing Industry Outlook, Evaluating Present Manufacturers, Analyzing Channels, and Offering a Comprehensive Forecast Till 2033

02-20-2024 10:37 AM CET | Health & Medicine

Press release from: The Business research company

Metagenomics Market

Metagenomics Market

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Metagenomics Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The metagenomics market size has grown rapidly in recent years. It will grow from $1.72 billion in 2023 to $2 billion in 2024 at a compound annual growth rate (CAGR) of 16.0%. The growth in the historic period can be attributed to microbiome research advancements, disease association studies, environmental monitoring needs, agricultural and food applications, biotechnology and industrial processes..

The metagenomics market size is expected to see rapid growth in the next few years. It will grow to $3.43 billion in 2028 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to precision medicine integration, microbial ecology understanding, one health initiatives, bioprospecting and drug discovery, diagnostic and therapeutic innovations.. Major trends in the forecast period include technological advancements in sequencing, integration of ai and machine learning, single-cell metagenomics, metagenomic data standardization, consumer wellness and personalized nutrition..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=10815&type=smp

Market Segmentation:
The metagenomics market covered in this report is segmented -
1) By Product: Instruments, Kits And Reagents, Software And Services
2) By Workflow: Sequencing, Pre-Sequencing, Data Analysis
3) By Application: Environmental, Clinical Diagnostics, Drug Discovery, Biotechnology, Food And Nutrition, Other Applications
4) By End User: Pharmaceutical Industries, Research Laboratories, Biotechnology Companies, Pathology Laboratories, Academic And Research Institutes

Major Driver - The Impact Of Rising Infectious Disease Incidence On The Metagenomics Market
The rise in the incidence of infectious diseases is significantly contributing to the growth of the metagenomics market. Infectious diseases, also known as transmissible diseases, refer to illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, and parasites, and can be transmitted from person to person or through other modes of transmission. Metagenomics is used to study infectious diseases by analyzing the genetic material of microbial communities. It allows for the comprehensive analysis of microbial communities associated with infectious agents, providing insights into their composition, genetic diversity, and potential interactions. For instance, in October 2022, according to an article published by the Pan American Health Organization, a US-based specialized agency of the United Nations, approximately 10.6 million people fell ill with tuberculosis (TB) in 2021. Therefore, the increasing prevalence of infectious diseases is driving the growth of the metagenomics market.

Competitive Landscape:
Major companies operating in the metagenomics market report are Illumina Inc., Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Novogene Co. Ltd., Oxford Nanopore Technologies Limited, Takara Bio USA Inc., BGI Group, Eurofins Scientific SE, Arc Bio LLC, Computomics GmbH, Enterome Bioscience, TAKARA BIO INC., Danaher Corporation, ELITechGroup, Metagenomi, Cosmosid Inc., Pattern Ag, Tiny Health, MATIS OHF, Adapsyn Bioscience, Precidiag Inc., One Codex Inc., MetaBi Inc., Zymo Research Corporation, Bluebee Holding BV, Maverix Biomics Inc., Lucigen Corporation

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/metagenomics-global-market-report

Top Trend - The Impact Of Technological Advancements On The Metagenomics Market
Technological advancements are the key trend gaining popularity in the metagenomics market. Major companies operating in the metagenomics market are focused on adopting new genomics technologies to improve their observation power and sustain their position in the market. For instance, in May 2023, CD Genomics, a US-based genomics services company, launched the Long-Read Metagenomic Sequencing service. With its state-of-the-art technology, researchers and scientists are better equipped to understand the complexity of microbial communities with unmatched accuracy and depth. Clients can enter a new era of metagenomics research by utilizing CD Genomics' cutting-edge technology and genomic knowledge. Its key features include enhanced resolution, species identification, functional annotation, and comparative analysis. This advanced method is expected to transform metagenomics research by offering previously unattainable insights into microbial communities.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Metagenomics Market Characteristics
3. Metagenomics Market Trends And Strategies
4. Metagenomics Market - Macro Economic Scenario
5. Metagenomics Market Size And Growth
…..
27. Metagenomics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Metagenomics Market 2024 - Providing Industry Outlook, Evaluating Present Manufacturers, Analyzing Channels, and Offering a Comprehensive Forecast Till 2033 here

News-ID: 3391059 • Views:

More Releases from The Business research company

Laparoscopy Devices Market to Grow to $17.13 Billion by 2028, Fueled by Minimally Invasive Surgery
Laparoscopy Devices Market to Grow to $17.13 Billion by 2028, Fueled by Minimall …
The laparoscopy devices market size has grown strongly in recent years. It will grow from $12.17 billion in 2023 to $13.1 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to improved surgeon training programs, enhanced safety and efficacy, shift towards minimally invasive surgery, evolution in energy-based devices, early adoption challenges. The laparoscopy devices market size is expected to
Inventory Tags Market to Grow to $7.04 Billion by 2028, Fueled by Barcode Technology
Inventory Tags Market to Grow to $7.04 Billion by 2028, Fueled by Barcode Techno …
The inventory tags market size has grown steadily in recent years. It will grow from $5.55 billion in 2023 to $5.8 billion in 2024 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to barcode technology adoption, development of rfid tags, manual inventory management systems, standardization of tagging systems, introduction of qr codes. The inventory tags market size is expected to see
Infection Control Market to Grow to $164.6 Billion by 2028: Major Trends, Technological Advancements, Growth Drivers And Forecast 2024-2033
Infection Control Market to Grow to $164.6 Billion by 2028: Major Trends, Techno …
The infection control market size has grown strongly in recent years. It will grow from $119.1 billion in 2023 to $126.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to healthcare-associated infections (hais), stringent regulatory standards, rising awareness of infectious diseases, globalization and travel, increased healthcare expenditure. The infection control market size is expected to see strong growth
Hyperpigmentation Disorder Market to Reach $7.73B by 2028 within Forecast Period 2024-2033 Driven by Surge in Pigmentation Disorders
Hyperpigmentation Disorder Market to Reach $7.73B by 2028 within Forecast Period …
The hyperpigmentation disorder treatment market size has grown strongly in recent years. It will grow from $5.3 billion in 2023 to $5.69 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to clinical trials and research, advances in chemical peels, cultural shift towards skincare, emphasis on non-invasive options, demand for natural products. The hyperpigmentation disorder treatment market size is

All 5 Releases


More Releases for Metagenomi

Metagenomic Sequencing Market by Technology (16S rRNA, Shotgun, Whole-genome), A …
The metagenomic sequencing market is expected to reach USD 4.3 billion by 2027 from USD 1.9 billion in 2022, at a CAGR of 18.4% during the forecast period. Growth in the metagenomic sequencing market is mainly driven by continuous technological innovations in NGS platforms, increasing initiatives and funding from government & private bodies for large-scale sequencing projects, declining costs of genome sequencing, and the significant applications of metagenomics in various